|
Summary of the clinical
investigations of DC current against cancer tumors
Science magazine #130, 1959, Humphrey and
Seal
Biophysical Approach Toward Tumor Regression
In Mice
Mice were given implants implants of sarcoma-180.
External electrodes (1" x 1.5") were placed on the skin, one on the tumor
area. 3mA of direct current was applied for 4.8 houra daily for 21 days,
at which time there was 60% total regression (tumor death) in all treated
mice.
Medical Hypotheses (1997) 49, pg 297-300
Targeting a key enzyme in cell growth: A novel
therapy for cancer
This study hypothesizes that the successes of studies
of direct electrical current (DC) against cancer tumors is due to the fact
that DC inhibits the RR enzyme which is necessary for cancer cell growth.
The paper lists other studies with these results; 1) 60% of the treated
mice had their tumors decrease/harden/drop-off using external electrodes
(1x1.5") at 3mA current for 4.8 hours daily for 21 days, 2) 88% tumor
destruction in hamsters using one external electrode and one implanted
needle electrode at 3mA for 1 hour daily for 4 days, 3) 98% average
reduction in tumor size in hamsters using one external electrode and one
implanted needle electrode at 2.4mA for 1 hour daily for 5
days.
Alternative Cancer Treatment with few side effects: The Electro
Carcinoma Therapy (ECT)
This is information from the German
clinic which references a 30% success rate (of total tumor destruction)
that the Chinese had with over 10,000 patients. An additional 40% had reduction
of tumor size. They applied the DC current to platinum wire electrodes, in
the form of needles, injected directly into the tumors. In contrast; the
German Marburg Institute works almost exclusively with metal electrode
plates applied to the skin which gives them the same results. Their
treatments are for 2-3 hours for at least 2 consecutive days. They vary
the current amount according to tumor size and density.
CLICK HERE for the
extended versions of the above studies.
CLICK HERE for the
page about our tumor electrifier, called the DC Electrifier.
In an
Bioelectrochemistry article "Electrochemical Treatment of
Tumors" details of the Chinese study results were listed as
such:
5 year survival rates after having received
ECT
| Malignant
tumors treated |
% survival rate |
| skin cancer |
80% |
| laryngeal cancer |
62% |
| tongue or lip cancer |
62% |
| prostate cancer |
50% |
| lung cancer |
39% |
| jaw + facial tumors |
39% |
| Benign tumors
treated |
% survival rate |
| thyroid tumors |
99% |
| prostate tumors |
71% |
| thyroid carcinoma |
53% |
| breast cancer |
50% |
| thyroid carcinoma |
53% |
| chest-abdominal wall metastases |
43% |
(These percentages are not in conflict with the 30%
rate of complete tumor elimination that the article by the Marburg
Institute lists because they aren't percentages of complete tumor
elimination, but rather of percentages of patients still alive after 5
years.)
Click here to read about how 80 Coulombs (per
square centimeter tumor size) electrical charge applied by platinum
electrodes in mice with tumors had long term success, whereas lower
total charge (electrical current times treatment time) was unsuccessful. Equal to 80 Coulombs is: 6mA of applied direct
current for 3 hrs 42 min, 5mA for 4 hr 26
min, etc. Here is the chart showing the continued
death of tumors at 80 Coulombs:
Effect of DEC on the growth
curve of fibrosarcoma Sa-37 tumor . The experimental groups
formed for the fibrosarcoma Sa-37 tumor were CG2; treated group with 36
C/cm3 , TG2-1; treated group with 63 C/cm3
, TG2-2; treated group with 80 C/cm3 , TG2-3. Each
experimental group is formed by 10
mice.
Swedish professor Bjorn Nordenstrom also had success with 80C per
square centimeter of tumor size in 20 patients with 26 inoperable lung
tumors. 12 out of the 26 tumors (46%) had complete regression
(elimination) and no signs of regrowth were detected after a 2-5 year
follow-up.
|